FDA approved new immunotherapy regimen for patients with melanoma
The U.S. Food and Drug Administration has approved a novel therapy for patients with metastatic or inoperable melanoma, an aggressive type of skin cancer.
Materials provided by Johns Hopkins Medicine. Note: Content may be edited for style and length.
Source link aaaaa